Unique investment in European television commercial for ellen®
The partnership with the leading German media company ProSiebenSat.1 gives Ellen access to 78 million households
Ellen AB, the biotech company listed on First North (Ticker: ELN), announced today that the company’s probiotic tampons will be marketed in an extensive television commercial spot via media company ProSiebenSat1 (P7S1), which operates television channels in 14 European countries, there among Sweden (Kanal 5 and Kanal 9). The investment is will be made over a three-year period and is valued at a minimum SEK 100 million.
Ellen’s German distributor, JnB, has signed a three-year Media for Revenue agreement with P7S1, under which they give JnB advertising space in exchange for part of the revenue from the sales of ellen®. Initially, the ellen® commercial will be shown on the German television channels ProSieben and Sat1 starting 1 July. P7S1 chose to invest in ellen® in strong competition with other products.
“It is incredible that one of the largest European media players has chosen to invest in Ellen’s probiotic products. I look forward to monitoring sales trends in one of our most important markets given the combination of this extensive TV commercial and our recently expanded distribution network via 500 drugstores in Germany and Austria,” comments Ellen's CEO Monica Wallter.
P7S1, listed on the Munich Stock Exchange, is one of the leading European media companies with 5,000 employees in 14 countries. It offers free TV financed through advertising. The media company reaches 78 million households making it the second largest player in Europe. In Germany, P7S1 is the leading channel for television commercials and it has more channels in other European markets, including Kanal 5 and Kanal 9 in Sweden.
Ever since its first launch in Sweden in 2002, Ellen’s patented probiotic tampons have received very favourable reviews from gynecologists and physicians in all its markets. Pharmacies have also welcomed ellen® as an innovative product, winning the German pharmacists award for best sanitary protection product in 2009. Ellen is fully equipped to meet the strong trend for natural health solutions.
Katarina Vielfort is this year’s recipient of the Ellen Scholarship
Katarina is a PhD student at the Department of Genetics, Microbiology and Toxicology at Stockholm University. In her research, she examines the function of lactic acid bacteria in the genital tract by studying their interaction with the pathogenic bacteria that causes gonorrhea. She also examines how lactic acid bacteria can affect cell cycles. Her research is aimed at gaining a better understanding of the complex interaction between normal flora and pathogenic bacteria, which in turn can lead to more effective treatment methods for bacteria-infection diseases.
